MX360649B - Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos. - Google Patents
Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos.Info
- Publication number
- MX360649B MX360649B MX2015011498A MX2015011498A MX360649B MX 360649 B MX360649 B MX 360649B MX 2015011498 A MX2015011498 A MX 2015011498A MX 2015011498 A MX2015011498 A MX 2015011498A MX 360649 B MX360649 B MX 360649B
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- peptides
- same
- skin rejuvenation
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000003716 rejuvenation Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 abstract 3
- 108010087806 Carnosine Proteins 0.000 abstract 3
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 abstract 3
- 229940044199 carnosine Drugs 0.000 abstract 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 210000002744 extracellular matrix Anatomy 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una composición para estimular la formación de uno o más componentes de la matriz extracelular en la piel o mucosa, caracterizada porque comprende N-Octanoil carnosina, el NO:1) en una composición en peso de 4:1:5, en donde la composición es formulada para la administración tópica o subcutánea.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361779601P | 2013-03-13 | 2013-03-13 | |
PCT/IB2014/001119 WO2014140890A2 (en) | 2013-03-13 | 2014-02-26 | Peptides for skin rejuvenation and methods of using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015011498A MX2015011498A (es) | 2016-05-31 |
MX360649B true MX360649B (es) | 2018-11-12 |
Family
ID=51263427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015011498A MX360649B (es) | 2013-03-13 | 2014-02-26 | Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos. |
Country Status (14)
Country | Link |
---|---|
US (3) | US9375398B2 (es) |
EP (1) | EP2970382B1 (es) |
JP (1) | JP6326601B2 (es) |
KR (1) | KR102276326B1 (es) |
CN (1) | CN105189531B (es) |
AR (1) | AR095276A1 (es) |
AU (1) | AU2014229557B2 (es) |
CA (1) | CA2902938C (es) |
HK (1) | HK1212363A1 (es) |
MX (1) | MX360649B (es) |
RU (1) | RU2666533C2 (es) |
SG (1) | SG11201506069RA (es) |
TW (1) | TWI652066B (es) |
WO (1) | WO2014140890A2 (es) |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX360649B (es) | 2013-03-13 | 2018-11-12 | Anteis Sa | Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos. |
WO2015069843A2 (en) | 2013-11-08 | 2015-05-14 | Hollister Incorporated | Oleophilic lubricated catheters |
BR112016013522B1 (pt) | 2013-12-20 | 2020-11-10 | Colgate-Palmolive Company | produto para higiene oral e branqueamento dos dentes com partículas de sílica em revestimento de núcleo |
EP3084037B1 (en) | 2013-12-20 | 2020-10-21 | Colgate-Palmolive Company | Core shell silica particles and uses thereof as an anti-bacterial agent |
BR112017000937B1 (pt) * | 2014-07-31 | 2022-01-25 | Kimberly-Clark Worldwide, Inc. | Composição antiaderente e lenço |
CA2972015A1 (en) * | 2014-12-23 | 2016-06-30 | Avon Products, Inc. | Peptides and their use in the treatment of skin |
JP2016150919A (ja) * | 2015-02-18 | 2016-08-22 | ピアス株式会社 | 塗布用化粧品組成物 |
MX2017011771A (es) | 2015-04-01 | 2017-12-04 | Kimberly Clark Co | Sustrato fibroso para la captura de bacterias gramnegativas. |
ITUB20152695A1 (it) | 2015-07-31 | 2017-01-31 | Metis Healthcare S R L | Composizione per l'aumento delle secrezioni umorali |
ES2907686T3 (es) | 2015-11-03 | 2022-04-26 | Zoetis Services Llc | Compuestos poliméricos sol-gel y sus usos |
US10729628B2 (en) | 2015-12-24 | 2020-08-04 | Conopco, Inc. | Tyrosinase inhibitors |
KR101843065B1 (ko) * | 2016-01-06 | 2018-03-28 | 바이오스펙트럼 주식회사 | 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물 |
CN106975523A (zh) * | 2016-01-19 | 2017-07-25 | 广州绿恒环保科技有限公司 | 一种新型的具有渗透分解功能光触媒液体 |
GB201601136D0 (en) | 2016-01-21 | 2016-03-09 | Mörgelin Matthias And Abdillahi Suado M | Novel polypeptides and medical uses thereof |
US12037497B2 (en) | 2016-01-28 | 2024-07-16 | Kimberly-Clark Worldwide, Inc. | Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface |
US20170216584A1 (en) * | 2016-01-29 | 2017-08-03 | Insung Information Co., Ltd. | Sheet mask for iontophoresis and mask assembly using the same |
BR112018015897B1 (pt) | 2016-02-04 | 2022-03-03 | Alastin Skincare, Inc | Composição tópica anidra para promover a reparação da pele, composições tópicas para promover a restauração da pele, composição tópica para aliviar contusões causadas por um procedimento cosmético e uso das mesmas |
US10988731B2 (en) * | 2016-04-29 | 2021-04-27 | Hope Biosciences, Llc | Formulation for storage, transportation, and delivery of protein rich conditioned medium |
JP6489487B2 (ja) * | 2017-01-20 | 2019-03-27 | 富比積生物科技股▲分▼有限公司 | テトラペプチド−3 gekgまたはペンタペプチド−3 gekgfにより変形性関節症を治療するための新規用途 |
ES2889579T3 (es) | 2017-02-17 | 2022-01-12 | Imertech Sas | Uso de un mineral particulado para reducir la contaminación |
AU2018243658A1 (en) * | 2017-03-30 | 2019-11-07 | Escape Therapeutics, Inc. | Decapeptide-12 modulation of sirtuin gene expression in epidermal keratinocyte progenitors |
KR101956572B1 (ko) * | 2017-04-05 | 2019-06-24 | 에이앤펩주식회사 | 기능성 펩타이드와 콜라겐 발효물을 포함하는 주름 개선용 조성물 |
CN107308101B (zh) * | 2017-06-13 | 2020-06-19 | 湖南御家化妆品制造有限公司 | 皮肤紧致组合物及其应用 |
JP6901801B2 (ja) * | 2017-06-14 | 2021-07-14 | バイオソリューション カンパニー・リミテッドBio Solution Co Ltd | 物質pを含むしわの改善または抗炎症化粧料組成物 |
US10258556B2 (en) * | 2017-06-19 | 2019-04-16 | Yu-Chun Liu | Anti-aging peptide, its composition and method of using the same |
BR112020002222A2 (pt) * | 2017-08-03 | 2020-07-28 | ALASTIN Skincare, Inc. | composições e métodos para melhora da flacidez da pele e do contorno corporal |
IT201700102009A1 (it) * | 2017-09-12 | 2019-03-12 | Promoitalia Group Spa | Composizione rigenerante e ad azione levigante per il trattamento degli inestetismi della pelle e relativo procedimento di preparazione |
AU2018334419A1 (en) * | 2017-09-18 | 2020-03-05 | Incube Labs Llc | Iontophoretic systems, kits and methods for transdermal delivery of cosmetic agents |
CN107857799B (zh) * | 2017-11-20 | 2021-06-04 | 陕西慧康生物科技有限责任公司 | 一种四肽-21的液相合成方法 |
MX2020006001A (es) | 2017-12-12 | 2022-04-12 | Colgate Palmolive Co | Composicion para el cuidado personal. |
CN108218956A (zh) * | 2018-02-23 | 2018-06-29 | 广州同隽医药科技有限公司 | 一种棕榈酰三肽-1的液相合成方法 |
FR3080532A1 (fr) * | 2018-04-26 | 2019-11-01 | Codexial Dermatologie | Preparation magistrale dermatologique |
CN112088010A (zh) * | 2018-05-04 | 2020-12-15 | 宝洁公司 | 用于治疗阴道干燥的组合物和方法 |
CN108744024A (zh) * | 2018-05-24 | 2018-11-06 | 海南芬森医疗器械有限公司 | 一种复配防疤痕液剂生物敷料及其制备方法 |
CN108715833B (zh) * | 2018-06-01 | 2021-09-14 | 天晴干细胞股份有限公司 | 一种负载血小板裂解液的微球制备方法 |
CN108888799A (zh) * | 2018-06-25 | 2018-11-27 | 东莞市联洲知识产权运营管理有限公司 | 一种具有驱虫性能的增强型复合纤维素医用敷料及其制备方法 |
KR101924894B1 (ko) * | 2018-07-25 | 2018-12-04 | 베네브바이오랩 주식회사 | 소음순 피부 치료용 피부연고 |
US11103455B2 (en) | 2018-08-02 | 2021-08-31 | ALASTIN Skincare, Inc. | Liposomal compositions and methods of use |
WO2020041695A1 (en) * | 2018-08-23 | 2020-02-27 | The General Hospital Corporation | Multifunctional skin patch |
KR101965607B1 (ko) * | 2018-08-27 | 2019-04-04 | (주)씨앤케이코스메디칼 | 불연속상 하이드로겔 및 옥수수 전분을 결합제로 포함하는 외력붕해성 고형 클렌저 및 이의 제조 방법 |
RU2681310C1 (ru) * | 2018-09-05 | 2019-03-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ первичной хирургической обработки инфицированных ран кожи и мягких тканей с использованием пептида Gly-His-Lys-D-Ala |
RU2681216C1 (ru) * | 2018-09-05 | 2019-03-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala |
US10881882B1 (en) * | 2018-12-21 | 2021-01-05 | Btl Medical Technologies S.R.O. | Methods and devices for tissue treatment |
GB201900728D0 (en) * | 2019-01-18 | 2019-03-06 | Univ Birmingham | Drug delivery system |
CZ308845B6 (cs) * | 2019-01-21 | 2021-07-07 | Globetech Innovation S.R.O | Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran |
KR102203356B1 (ko) * | 2019-01-28 | 2021-01-18 | (주)더마펌 | 피부 노화방지 및 주름개선용 펩타이드 및 이를 포함하는 조성물 |
US20200237626A1 (en) * | 2019-01-28 | 2020-07-30 | Jamrm, Llc | Anti-Aging Corrective and Protective Formulation and Methods |
EP3930740A4 (en) * | 2019-02-25 | 2022-12-21 | Topix Pharmaceuticals, Inc. | METHODS, COMPOSITIONS, FILMS FOR THERAPEUTIC SKIN TREATMENTS |
CN110257140B (zh) * | 2019-06-17 | 2022-02-15 | 厦门路辉科技有限公司 | 一种光学高效芯取磨边液 |
WO2021021588A1 (en) * | 2019-07-26 | 2021-02-04 | Photokinetix Holdings Inc. | Intravaginal devices, compositions and methods to treat atrophic vaginitis |
CN110652484A (zh) * | 2019-11-04 | 2020-01-07 | 武汉赛锐希斯科技有限公司 | 一种针对银屑病肤质日常维护的洗发水配方 |
CN110833514B (zh) * | 2019-12-10 | 2023-05-09 | 广州赛莱拉干细胞科技股份有限公司 | 多肽冻干粉及其在制备抗衰老的化妆品中的应用 |
BR112022013144A2 (pt) * | 2020-01-21 | 2022-09-06 | Asc Regenity Ltd | Formulação cosmética para administração tópica compreendendo peptídeos que melhoram o aspecto e a regeneração da pele |
US12077780B2 (en) * | 2020-02-14 | 2024-09-03 | Allergan Sales, Llc | Conditioned medium from cells cultured under hypoxic conditions and uses thereof |
CN114007578A (zh) * | 2020-02-28 | 2022-02-01 | C·扎维拉 | 毛发增长及头皮制剂 |
US11590073B2 (en) | 2020-06-09 | 2023-02-28 | The Procter & Gamble Company | Methods and compositions for reducing the feeling of vaginal dryness |
CN111939458A (zh) * | 2020-08-25 | 2020-11-17 | 四川大学 | 一种具有超薄柔性背衬层的微针贴片及其制备方法 |
FR3117014B1 (fr) * | 2020-12-07 | 2024-01-12 | Oreal | Compositions de soin de la peau incluant l’acide azélaïque et procédés de fabrication d’une composition de soin de la peau |
US11464727B2 (en) * | 2020-09-29 | 2022-10-11 | Serendipity Technologies Llc | Reduced-cost cosmetic formulations that reduce visible signs of ageing |
WO2022140467A1 (en) * | 2020-12-21 | 2022-06-30 | Samson Pharma, Llc | Topical compositions and methods of treating skin diseases and conditions with such compositions |
US20220218584A1 (en) * | 2021-01-13 | 2022-07-14 | Allergan Sales, Llc | Topical composition and method of use |
WO2022157587A1 (en) * | 2021-01-23 | 2022-07-28 | Cellix Bio Private Limited | A composition comprising lidocaine, l-carnosine and dexpanthenol |
CN114469766A (zh) * | 2021-02-02 | 2022-05-13 | 江苏巴帝恩生物科技有限公司 | 一种含葡萄糖电解质的保湿及改善肌肤屏障的化妆品组成物 |
KR102259668B1 (ko) * | 2021-03-31 | 2021-06-01 | 신승연 | 프로테오글리칸-함유 크림 화장료 조성물 및 그의 제조방법 |
CN113376269A (zh) * | 2021-05-14 | 2021-09-10 | 广东药科大学 | 一种十一烯酰基苯丙氨酸的含量测定方法 |
US20220387284A1 (en) * | 2021-05-25 | 2022-12-08 | Allergan Sales, Llc | Topical composition and method of use |
CN113368004B (zh) * | 2021-06-15 | 2022-07-29 | 郑州三铠化妆品有限公司 | 一种具有抗衰修复功效的多肽组合物及其制备方法与应用 |
CN113440435B (zh) * | 2021-07-07 | 2022-08-09 | 珀莱雅化妆品股份有限公司 | 一种皮肤抗衰老组合物的制备方法 |
TWI818301B (zh) * | 2021-08-20 | 2023-10-11 | 富比積生物科技股份有限公司 | 寡肽於治療牙齦發炎和牙齦萎縮及修復口腔黏膜之用途 |
US20230129935A1 (en) * | 2021-10-22 | 2023-04-27 | Vaginal Biome Science, Inc. | System, product and method for maintaining the vaginal microbiome |
US20230130124A1 (en) * | 2021-10-25 | 2023-04-27 | Cosmed Pharmaceutical Co., Ltd. | Cosmetic microneedle |
CN114392393A (zh) * | 2021-12-17 | 2022-04-26 | 重庆米茜尔医疗美容门诊部有限公司 | 一种用于皮肤自我修复的皮下注射组合物及其使用方法 |
CN113956244B (zh) * | 2021-12-21 | 2022-03-29 | 浙江湃肽生物有限公司深圳分公司 | 一种用于皮肤复新的肌肽衍生物及其用途 |
US20230201105A1 (en) * | 2021-12-23 | 2023-06-29 | Guangen Xiang | Lip Gloss Formulation |
CN114369904A (zh) * | 2021-12-24 | 2022-04-19 | 浙江鹿达科技有限公司 | 一种抗菌无纺布卫生材料及其制备工艺 |
KR20230099481A (ko) * | 2021-12-27 | 2023-07-04 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20230099483A (ko) * | 2021-12-27 | 2023-07-04 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20230099480A (ko) * | 2021-12-27 | 2023-07-04 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20230099482A (ko) * | 2021-12-27 | 2023-07-04 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
CN114452270B (zh) * | 2022-01-19 | 2022-09-27 | 广东省第二中医院(广东省中医药工程技术研究院) | 一种用于治疗骨关节炎的微针贴及其制备方法 |
CN114344217B (zh) * | 2022-01-24 | 2024-07-09 | 深圳市琉璃光生物科技有限公司 | 一种膏状抗氧化护肤品及其生产工艺 |
CN115024997B (zh) * | 2022-05-24 | 2023-11-17 | 彭氏(惠州)实业发展有限公司 | 具有抗皮肤衰老功效的化妆品组合物 |
CN115161274A (zh) * | 2022-06-08 | 2022-10-11 | 菲尔生物工程技术有限公司 | 一种脂肪干细胞提取物的抗皱精华液及其制备方法 |
CN115261419B (zh) * | 2022-07-23 | 2023-07-21 | 广州市博之越精细化工有限公司 | 一种γ-聚谷氨酸钠溶液的制备方法 |
CN115607467B (zh) * | 2022-09-27 | 2023-05-30 | 谢志辉生物医药研究院(广州)有限公司 | 一种含有壬二酸的低刺激性与美白、控油组合物 |
WO2024097166A1 (en) | 2022-11-02 | 2024-05-10 | Nutrition & Biosciences USA 4, Inc. | Compositions comprising xanthan gum and crystalline alpha-1,3-glucan |
KR20240072372A (ko) * | 2022-11-15 | 2024-05-24 | 웰펩 주식회사 | 가려움 유발 사이토카인 제어 효과가 우수한 펩티도미메틱 및 이를 포함하는 화장료 조성물 |
KR20240086708A (ko) * | 2022-11-18 | 2024-06-19 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20240086709A (ko) * | 2022-11-18 | 2024-06-19 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR102620622B1 (ko) * | 2023-09-08 | 2024-01-04 | 주식회사 제이포셀 | 보관 안정성이 향상된 egf를 함유하는 화장료 조성물 |
CN117731544A (zh) * | 2023-12-19 | 2024-03-22 | 广州集妍化妆品科技有限公司 | 一种含杏仁酸的具有靶向透皮递送功能的淡斑淡印美白增效组合物、其制备方法及其应用 |
CN117838563A (zh) * | 2024-01-09 | 2024-04-09 | 杭州悦萱堂化妆品有限公司 | 一种抗糖复合物及抗糖化妆剂组合物及制备方法 |
CN117982629B (zh) * | 2024-02-19 | 2024-07-19 | 北京盛美诺生物技术有限公司 | 一种iii型小分子胶原蛋白肽在改善面部肤质中的应用 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2668365B1 (fr) * | 1990-10-25 | 1994-12-23 | Sederma Sa | Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique. |
DE69225631T2 (de) * | 1991-02-19 | 1998-12-17 | Cci Corp., Gifu | Acylaminosäure-Verbindungen und Verfahren zu ihrer Herstellung |
FR2701948B1 (fr) | 1993-02-22 | 1996-07-26 | Exsymol Sa | Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires. |
FR2711990B1 (fr) | 1993-11-05 | 1995-12-08 | Exsymol Sa | Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires. |
EP0920445B1 (fr) | 1996-08-23 | 2003-01-02 | Sederma S.A. | Peptides synthetiques et leur utilisation dans les compositions cosmetiques ou dermopharmaceutiques |
FR2756565B1 (fr) | 1996-12-04 | 1998-12-31 | Oreal | Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie |
FR2783169B1 (fr) | 1998-09-15 | 2001-11-02 | Sederma Sa | Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution) |
FR2791684B1 (fr) | 1999-03-30 | 2001-05-11 | Sederma Sa | Composition cosmetiques ou dermopharmaceutiques contenant le tripeptide n-n-biotinyl-gly-his-lys pour prevenir, reduire ou supprimer la chute des cheveux ainsi que pour favoriser leur repousse |
FR2802413B1 (fr) | 1999-12-17 | 2003-10-31 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause |
AUPQ515000A0 (en) * | 2000-01-19 | 2000-02-10 | Grigg, Geoffrey Walter | Treatment of uv induced immunosuppression |
FR2805744B1 (fr) | 2000-03-03 | 2006-08-25 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques contenant le dipeptide val-trp pour faciliter le drainage lymphatique et diminuer la masse adipeuse |
FR2810323B1 (fr) | 2000-06-16 | 2002-09-06 | Shiseido Int France | Utilisation cosmetique d'un lipopeptide |
EP1455744A2 (de) * | 2001-10-13 | 2004-09-15 | Beiersdorf AG | Kosmetische und/oder dermatologische wirkstoffkombination |
EP1551399A4 (en) | 2002-09-30 | 2011-01-05 | Mark A Babizhayev | METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT |
WO2004064866A1 (ja) | 2003-01-20 | 2004-08-05 | Innovative Vision Products, Inc. | カルノシナーゼ阻害剤とl−カルノシン類との併用および組成物 |
US7863417B2 (en) | 2003-05-08 | 2011-01-04 | Dsm Ip Assets B.V. | Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
FR2854897B1 (fr) | 2003-05-12 | 2007-05-04 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane. |
AU2003296248A1 (en) * | 2003-11-17 | 2005-06-08 | Sederma | Compositions containing mixtures of tetrapeptides and tripeptides |
ES2261036B1 (es) * | 2004-10-05 | 2007-12-16 | Lipotec, S.A. | Peptidos sinteticos que disminuyen o eliminan las bolsas formadas bajo el contorno inferior de los ojos y su uso en composiciones cosmeticas o dermofarmaceuticas. |
US7776915B2 (en) * | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
US20070020220A1 (en) * | 2005-04-27 | 2007-01-25 | Procter & Gamble | Personal care compositions |
AR058140A1 (es) * | 2005-10-24 | 2008-01-23 | Wyeth Corp | Metodo de produccion proteica utilizando compuestos anti-senescencia |
CN1810828A (zh) * | 2006-03-03 | 2006-08-02 | 华东师范大学 | 一种脂肪酸-肌肽复合物及其制备方法 |
US20070237735A1 (en) * | 2006-03-31 | 2007-10-11 | Laboratoires Dermo-Cosmetik Inc. | Anti-aging composition, kit and method of use |
US8586541B2 (en) | 2006-06-01 | 2013-11-19 | Therapeutic Peptides, Inc. | Polymeric biosurfactants |
PT2409988E (pt) * | 2006-06-13 | 2015-10-12 | Helix Biomedix Inc | Fragmentos peptídicos para induzir síntese de proteínas da matriz extracelular |
EP2065029B1 (en) * | 2007-11-30 | 2013-04-17 | Evonik Goldschmidt GmbH | Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K |
ES2342754B1 (es) * | 2008-10-03 | 2011-05-11 | Lipotec, S.A. | Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas, cuero cabelludo y/o cabello y su uso en composiciones cosmeticas o farmaceuticas. |
FR2941231B1 (fr) | 2009-01-16 | 2016-04-01 | Sederma Sa | Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques. |
CA2748375C (en) | 2009-01-16 | 2017-08-01 | Neocutis Sa | Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions |
FR2945939B1 (fr) | 2009-05-26 | 2011-07-15 | Sederma Sa | Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane. |
EP2437602A4 (en) | 2009-06-05 | 2014-02-19 | Aciex Therapeutics Inc | OPHTHALMIC FORMULATIONS, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THEIR USE |
FR2946251B1 (fr) * | 2009-06-08 | 2011-05-20 | Oreal | Composition cosmetique comprenant un derive d'acide salicylique et de la carnosine. |
WO2011109469A1 (en) | 2010-03-03 | 2011-09-09 | Neocutis Sa | Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
FR2975904B1 (fr) * | 2011-06-01 | 2013-08-23 | Sederma Sa | Nouvelle utilisation topique, cosmetique ou dermopharmaceutique, d'un melange comprenant un tripeptide du type ghk et un tetrapeptide du type gqpr |
MX360649B (es) | 2013-03-13 | 2018-11-12 | Anteis Sa | Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos. |
-
2014
- 2014-02-26 MX MX2015011498A patent/MX360649B/es active IP Right Grant
- 2014-02-26 RU RU2015131719A patent/RU2666533C2/ru active
- 2014-02-26 CN CN201480012627.7A patent/CN105189531B/zh active Active
- 2014-02-26 AU AU2014229557A patent/AU2014229557B2/en active Active
- 2014-02-26 JP JP2015562393A patent/JP6326601B2/ja active Active
- 2014-02-26 EP EP14747114.8A patent/EP2970382B1/en active Active
- 2014-02-26 WO PCT/IB2014/001119 patent/WO2014140890A2/en active Application Filing
- 2014-02-26 CA CA2902938A patent/CA2902938C/en active Active
- 2014-02-26 KR KR1020157025086A patent/KR102276326B1/ko active IP Right Grant
- 2014-02-26 SG SG11201506069RA patent/SG11201506069RA/en unknown
- 2014-03-04 TW TW103107248A patent/TWI652066B/zh active
- 2014-03-10 US US14/202,418 patent/US9375398B2/en active Active
- 2014-03-12 AR ARP140100889A patent/AR095276A1/es unknown
-
2016
- 2016-01-12 HK HK16100287.4A patent/HK1212363A1/xx unknown
- 2016-05-25 US US15/164,686 patent/US10543195B2/en active Active
-
2019
- 2019-12-10 US US16/709,838 patent/US11331305B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20200093799A1 (en) | 2020-03-26 |
HK1212363A1 (en) | 2016-06-10 |
CA2902938A1 (en) | 2014-09-18 |
US10543195B2 (en) | 2020-01-28 |
RU2666533C2 (ru) | 2018-09-11 |
CN105189531A (zh) | 2015-12-23 |
US9375398B2 (en) | 2016-06-28 |
TW201521758A (zh) | 2015-06-16 |
WO2014140890A3 (en) | 2015-04-09 |
KR102276326B1 (ko) | 2021-07-13 |
AU2014229557B2 (en) | 2017-12-07 |
US20140309173A1 (en) | 2014-10-16 |
RU2015131719A (ru) | 2017-04-20 |
JP6326601B2 (ja) | 2018-05-23 |
US11331305B2 (en) | 2022-05-17 |
SG11201506069RA (en) | 2015-09-29 |
EP2970382A2 (en) | 2016-01-20 |
EP2970382B1 (en) | 2019-09-25 |
AR095276A1 (es) | 2015-09-30 |
AU2014229557A1 (en) | 2015-10-22 |
MX2015011498A (es) | 2016-05-31 |
JP2016516023A (ja) | 2016-06-02 |
WO2014140890A2 (en) | 2014-09-18 |
CN105189531B (zh) | 2020-02-21 |
CA2902938C (en) | 2021-06-01 |
TWI652066B (zh) | 2019-03-01 |
KR20150126621A (ko) | 2015-11-12 |
US20160271109A1 (en) | 2016-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2902938C (en) | Peptides for skin rejuvenation and methods of using the same | |
ZA202208792B (en) | Methods of treating and preventing graft versus host disease | |
MX2017002271A (es) | Composiciones y metodos para el tratamiento de trastornos neurologicos. | |
MA40437A (fr) | Méthodes de traitement du cancer faisant appel à des inhibiteurs de tigit et à des agents anticancéreux | |
EA201691079A1 (ru) | Комбинированная терапия для лечения онкологического заболевания | |
MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
MX2016007801A (es) | Pirimidopirimidinonas utiles como iniciadores de wee-1 cinasa. | |
EA201390506A1 (ru) | Полипептиды, которые связывают компонент с5 комплемента человека | |
MX2015015249A (es) | Peptidos terapeuticos. | |
MX2022014277A (es) | Metodos para una mejor administracion de agentes activos a tumores. | |
GEP20217317B (en) | Combination therapy for the treatment of cancer | |
EA201591925A1 (ru) | Терапевтические композиции и их применение | |
MX2016002580A (es) | Combinacion de un inhibidor de alk y un inhibidor de cdk para el tratamiento de enfermedades celulares proliferativas. | |
EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
WO2014151369A3 (en) | Stabilized ezh2 peptides | |
PH12016500978A1 (en) | Piperazine derivatives having multimodal activity against pain | |
MX2016006604A (es) | Derivados de piperidina con actividad multimodal contra el dolor. | |
EP4385563A3 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
MX2016006603A (es) | Compuestos piperidinicos con actividad multimodal contra el dolor. | |
MX2015013091A (es) | Metodos mejorados de uso para secretoglobinas humanas recombinantes. | |
MX364528B (es) | Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas. | |
MX2015013755A (es) | Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis. | |
PH12016501811A1 (en) | Cosmetic composition for skin moisturizing containing minerals and quinoa extract | |
MX2016005614A (es) | Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos. | |
MX2016002930A (es) | Moduladores del receptor x hepatico (lxr). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: ANTEIS SA |
|
FG | Grant or registration |